Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.
2.

The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Mathers AJ, Peirano G, Pitout JD.

Clin Microbiol Rev. 2015 Jul;28(3):565-91. doi: 10.1128/CMR.00116-14. Review.

3.

Urinary tract infections attributed to diverse ExPEC strains in food animals: evidence and data gaps.

Singer RS.

Front Microbiol. 2015 Feb 4;6:28. doi: 10.3389/fmicb.2015.00028.

4.

Plasmid flux in Escherichia coli ST131 sublineages, analyzed by plasmid constellation network (PLACNET), a new method for plasmid reconstruction from whole genome sequences.

Lanza VF, de Toro M, Garcillán-Barcia MP, Mora A, Blanco J, Coque TM, de la Cruz F.

PLoS Genet. 2014 Dec 18;10(12):e1004766. doi: 10.1371/journal.pgen.1004766.

5.

Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.

Jamborova I, Dolejska M, Vojtech J, Guenther S, Uricariu R, Drozdowska J, Papousek I, Pasekova K, Meissner W, Hordowski J, Cizek A, Literak I.

Appl Environ Microbiol. 2015 Jan;81(2):648-57. doi: 10.1128/AEM.02459-14.

6.

Overlapped sequence types (STs) and serogroups of avian pathogenic (APEC) and human extra-intestinal pathogenic (ExPEC) Escherichia coli isolated in Brazil.

Maluta RP, Logue CM, Casas MR, Meng T, Guastalli EA, Rojas TC, Montelli AC, Sadatsune T, de Carvalho Ramos M, Nolan LK, da Silveira WD.

PLoS One. 2014 Aug 12;9(8):e105016. doi: 10.1371/journal.pone.0105016.

7.

Escherichia coli ST131, an intriguing clonal group.

Nicolas-Chanoine MH, Bertrand X, Madec JY.

Clin Microbiol Rev. 2014 Jul;27(3):543-74. doi: 10.1128/CMR.00125-13. Review.

8.

High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?

Strand L, Jenkins A, Henriksen IH, Allum AG, Grude N, Kristiansen BE.

BMC Res Notes. 2014 Jun 19;7:376. doi: 10.1186/1756-0500-7-376.

9.

A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Banerjee R, Johnson JR.

Antimicrob Agents Chemother. 2014 Sep;58(9):4997-5004. doi: 10.1128/AAC.02824-14. Review.

10.

Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes.

Mora A, Dahbi G, López C, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso MP, Denamur E, Blanco J.

PLoS One. 2014 Jan 30;9(1):e87025. doi: 10.1371/journal.pone.0087025.

11.
12.

Escherichia coli in Europe: an overview.

Allocati N, Masulli M, Alexeyev MF, Di Ilio C.

Int J Environ Res Public Health. 2013 Nov 25;10(12):6235-54. doi: 10.3390/ijerph10126235. Review.

13.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH)..

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13.

14.

Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.

Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL.

J Clin Microbiol. 2013 Oct;51(10):3270-6. doi: 10.1128/JCM.01315-13.

15.

Longitudinal monitoring of extended-spectrum-beta-lactamase/AmpC-producing Escherichia coli at German broiler chicken fattening farms.

Laube H, Friese A, von Salviati C, Guerra B, Käsbohrer A, Kreienbrock L, Roesler U.

Appl Environ Microbiol. 2013 Aug;79(16):4815-20. doi: 10.1128/AEM.00856-13.

16.
17.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933.

18.

Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands.

Voets GM, Platteel TN, Fluit AC, Scharringa J, Schapendonk CM, Stuart JC, Bonten MJ, Leverstein-van Hall MA; National ESBL Surveillance Working Group..

PLoS One. 2012;7(12):e52102. doi: 10.1371/journal.pone.0052102. Erratum in: PLoS One. 2015;9(9):107786. Hall, Maurine A L [corrected to Leverstein-van Hall, Maurine A].

19.

Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, Germany.

Guenther S, Bethe A, Fruth A, Semmler T, Ulrich RG, Wieler LH, Ewers C.

PLoS One. 2012;7(11):e50331. doi: 10.1371/journal.pone.0050331.

20.

Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW.

Antimicrob Agents Chemother. 2013 Jan;57(1):490-7. doi: 10.1128/AAC.01025-12.

Supplemental Content

Support Center